Floatz logo

Vinorelbine

Rectal Adenocarcinoma

National Cancer Institute (NCI)Phase 2Dormant
CCC
54/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
42/ 100
Competitive Position
73/ 100

Competitive context

37 Active assets in the Rectal Adenocarcinoma cohort.

Asset / SponsorPhaseRating
FLUOROURACILUM
Sixth Affiliated Hospital, Sun Yat-sen University
Phase 3BBB
Calcium folinate pentahydrate
Sixth Affiliated Hospital, Sun Yat-sen University
Phase 3BB
Eloxatin
Sixth Affiliated Hospital, Sun Yat-sen University
Phase 3BB
Capecitabine
Chongqing University Cancer Hospital
Phase 3B
METRONIDAZOLE
AC Camargo Cancer Center
Phase 4B

View all 45 →

Same molecule, other indications

Vinorelbine is also rated in:

HER2 positive breast carcinomaDormant
BBB
Indicative ·
74 / 100
View asset →
Recurrent Breast CarcinomaDormant
BBB
Indicative ·
72 / 100
View asset →
Hodgkins lymphomaDormant
BBB
Indicative ·
72 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →